Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Memorial Sloan Kettering Cancer Center.
J Natl Compr Canc Netw. 2023 Jul;21(7):694-704. doi: 10.6004/jnccn.2023.0035.
In 2023, the NCCN Guidelines for Hepatobiliary Cancers were divided into 2 separate guidelines: Hepatocellular Carcinoma and Biliary Tract Cancers. The NCCN Guidelines for Biliary Tract Cancers provide recommendations for the evaluation and comprehensive care of patients with gallbladder cancer, intrahepatic cholangiocarcinoma, and extrahepatic cholangiocarcinoma. The multidisciplinary panel of experts meets at least on an annual basis to review requests from internal and external entities as well as to evaluate new data on current and emerging therapies. These Guidelines Insights focus on some of the recent updates to the NCCN Guidelines for Biliary Tract Cancers as well as the newly published section on principles of molecular testing.
在 2023 年,NCCN 肝胆肿瘤治疗指南分为 2 个独立的指南:肝细胞癌和胆道肿瘤。NCCN 胆道肿瘤治疗指南为胆囊癌、肝内胆管癌和肝外胆管癌患者的评估和综合治疗提供了推荐意见。多学科专家组每年至少开会一次,以审议内部和外部实体的请求,以及评估当前和新兴治疗方法的新数据。本指南要点重点介绍了 NCCN 胆道肿瘤治疗指南的一些最新更新,以及新发布的关于分子检测原则的章节。